MedPath

Sbi Alapharma Canada, Inc.

🇨🇦Canada
Ownership
Subsidiary
Employees
-
Market Cap
-
Website

Fluorescence Imaging of Carcinoma During Breast Conserving Surgery

Phase 3
Recruiting
Conditions
Breast Neoplasm Female
Breast Cancer
Interventions
Drug: Placebo
Device: Eagle V1.2 Imaging System
First Posted Date
2021-03-24
Last Posted Date
2023-08-04
Lead Sponsor
SBI ALApharma Canada, Inc.
Target Recruit Count
370
Registration Number
NCT04815083
Locations
🇺🇸

Aurora St. Luke's Medical Centre, Milwaukee, Wisconsin, United States

🇺🇸

Orlando Health, Inc., Orlando, Florida, United States

🇺🇸

Montefiore Medical Center, Bronx, New York, United States

© Copyright 2025. All Rights Reserved by MedPath